Cargando…

Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis: the evidence to date

Siponimod (BAF312) is a synthetic molecule belonging to the sphingosine-1-phosphate (S1P) modulator family, which has putative neuroprotective properties and well-characterized immunomodulating effects mediated by sequestration of B and T cells in secondary lymphoid organs. Compared to fingolimod (i...

Descripción completa

Detalles Bibliográficos
Autor principal: Gajofatto, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679692/
https://www.ncbi.nlm.nih.gov/pubmed/29138536
http://dx.doi.org/10.2147/DDDT.S122249